Certara to Participate in Upcoming Investor Conferences
21 Agosto 2024 - 3:15PM
Certara, Inc. (Nasdaq: CERT), a global leader in model-informed
drug development, today announced that Company management will
participate in the following investor conferences:
- Morgan Stanley 22nd
Annual Global Healthcare ConferenceDate
and Time: Wednesday, September 4 at 4:05 p.m. ET
- Baird Global Healthcare ConferenceDate
and Time: Wednesday, September 11 at 10:15 a.m. ET
Live webcasts for each of the conferences will be available on
Certara’s investor relations website at https://ir.certara.com and
will be available for replay for at least 90 days thereafter.
About CertaraCertara accelerates medicines
using biosimulation software, technology, and services to transform
traditional drug discovery and development. Its clients include
more than 2,400 biopharmaceutical companies, academic institutions,
and regulatory agencies across 66 countries. Learn more at
certara.com.
Investor Relations Contact:David
DeuchlerGilmartin Groupir@certara.com
Media Contact:Alyssa
Horowitzcertara@pancomm.com
Certara (NASDAQ:CERT)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Certara (NASDAQ:CERT)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024